Search
Menu
Trioptics GmbH - Worldwide Benchmark 4-24 LB

BD Biosciences

Facebook X LinkedIn Email
BD Biosciences of San Jose, Calif., and Dynomics BV of Rotterdam, the Netherlands, have reached an agreement that grants the former an exclusive worldwide license to specific intellectual property related to the flow cytometry detection of fusion proteins. Detection and identification of the proteins are important markers for diagnosing and monitoring leukemia and malignant lymphoma.Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: May 2006
    BiophotonicsBusinessenergyRapidScan

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.